Celera and Collaborators Discover a Genetic Marker Associated with Severe Coronary Artery Disease
Carriers of gene variant exhibit an approximate 3-fold increased risk of disease
18-Jun-2007 -
Celera, an Applera Corporation business, and its collaborators at the Cleveland Clinic, University of California, San Francisco (UCSF), the Scripps Institute, and Queens University, Canada, announced the publication of a paper describing a novel variant of the LPA gene that is associated with an ...
amino acids
Applera
cardiovascular diseases
+7